|
Nevada Environmental Tobacco Smoke and Health Study Clinical Trials Data presented on Clinical Trials Search is not meant to be a substitute for qualified medical advice, visits or professional assistance with a genuine dr.. We are not doctors. Always consult your mD about Nevada Environmental Tobacco Smoke and Health Study conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Nevada Environmental Tobacco Smoke and Health Study Clinical research trials and Nevada Environmental Tobacco Smoke and Health Study medical trials take place in many of places throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the effectiveness of new does drugs. The purpose of the studies / projects is to solve specific human healthcare questions. Clinical trials are a popular way for mDs, government agencies, and private sector companies to find cures for all varieties of conditions, like Nevada Environmental Tobacco Smoke and Health Study. Nevada Environmental Tobacco Smoke and Health Study Clinical Trials and other clinical trials allow for volunteers to have health treatment options before they are available to the masses. Many times the human subjects acquire professional assistance for free of charge, and sometimes they are compensated for their time. Occasionally there is a cost for a Nevada Environmental Tobacco Smoke and Health Study clinical trial. Test subjects typically obtain the finest healthcare available for their Nevada Environmental Tobacco Smoke and Health Study condition. Dangers are a reality, nevertheless, and might include additional or frequent doctor trips, medical dangers (possibly life-jeopardising), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "N" Clinical Trials Conditions > Nevada Environmental Tobacco Smoke and Health Study  Nevada Environmental Tobacco Smoke and Health Study
Nevada Environmental Tobacco Smoke and Health Study
For Condition: Cancer,Cardiovascular Disease
Status: Recruiting
Sponsor(s): National Institute of Environmental Health Sciences (NIEHS) ,
Synopsis: Workplace exposure to secondhand cigarette smoke or environmental tobacco smoke (ETS)is widespread, effecting between 19 and 49% of the U.S. workforce. The first part of this study is designed to test whether exposure to ETS in the workplace effects a person's risk of developing chronic diseases such as cardiovascular disease and cancer. The second part of this study is designed to test whether antioxidant supplementation in this group of ETS exposed individuals can reduce their risk of developing chronic disease. The study will look at 375 non-smokers who either work on a casino floor or as bartenders or cocktail servers. Initial baseline data will be collected (questionnaires and blood samples taken) and the subjects will be randomized into one of three groups, placebo, low antioxidant supplementation and high antioxidant supplementation. They will be followed over a two-year period, coming in for follow-up testing every six months. Statistical analysis will be conducted to see whether this group of ETS exposed individuals has a greater risk of developing chronic disease and whether the use of antioxidant supplements can moderate any risks.
Details:
Eligibility:
Study Type: Interventional, Prevention, Randomized, Double-Blind, Placebo Control, Factorial Assignment, Efficacy Study
Minimum Age/Maximum Age: 22 Years/65 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: Non-smoker Work in a casino - on the casino floor or work as a bartender or cocktail server for at least 1 year Do not take antioxidant supplements Healthy - not diagnosed with any major chronic diseases. Exclusion Criteria: Blood pressure SBP>200,<85 DBP>100, <40 Pulse >120, <45 Cholesterol >400 Triglycerides >700 Blood Cotinine >10 ng/ml BMI >35
Total Enrollment: 375
Location and Contact Information:
Overall Study Official:
ChrisPritsos, Principal Investigator, University of Nevada, Reno
ETS Clinic, University of Nevada, School of Medicine, 1707 W. Charleston Blvd Suite 100 *Recruiting*
Las Vegas, Nevada, 89102
United States
Recruiting Katherine Robinson 702-671-5038
Additional Information:
Study ID Numbers: 9520-CP-001;
Study Start Date:
Record last reviewed: September 2002
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00046306
Other Cardiovascular Disease Studies:
1. Vinorelbine and XR9576 to Treat Cancer
2. Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of the HER2/neu Protein
3. Study of the Farnesyl Transferase Inhibitor, R115777, in Combination with Topotecan (NYU 99-32)
4. Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer
5. (1)H-Nuclear Magnetic Resonance Spectroscopic Imaging of the Brain in Patients who Receive Neurotoxic Therapy
Related Studies:
Other Cardiovascular Disease Clinical Trials
Other Nevada Clinical Trials
Other Las Vegas Clinical Trials
Nevada Environmental Tobacco Smoke and Health Study
|
|
|
|
|
|
|
|
